| Announce Date | 08/05/2025 | 
| EPS Normalized Actual | $0.52 (Beat by $0.05) | 
| EPS GAAP Actual | $0.52 (Beat by $0.05) | 
| Revenue Actual | $0.776B | 
| Revenue Surprise | Beat by $776M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.38539 | 
| EPS GAAP Estimate | $0.38539 | 
| Revenue Estimate | $0.743367942B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2027 | 2.16 | 36.28 | 2.14668 | 2.17732 | 1 | 
| Dec 2023 | 1.305 | 60.05 | 1.29044 | 1.32295 | 4 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.45 | 0.45 | 0.776B | 5.93% | 776M | 
| FQ1 2025 (Mar 2025) | 0.34 | 0.34 | 0.705B | 100% | 705M | 
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 0.739B | 100% | 739M | 
| FQ3 2024 (Sep 2024) | 0.44 | 0.44 | 0.731B | 7.52% | 731M | 
| FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 0.73B | 5.62% | 730M | 
| FQ1 2022 (Mar 2022) | 0.43 | 0.43 | 0.623B | 100% | 623M | 
| FQ2 2022 (Jun 2022) | 0.3 | 0.3 | 0.645B | 100% | 645M | 
| FQ3 2022 (Sep 2022) | 0.35 | 0.35 | 0.623B | 100% | 623M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.38539
Consensus Revenue Estimates
0.743367942B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.55093 | -- | 0.54393 | 0.55606 | 2 | 
| FQ3 2027 (Sep 2027) | 0.58651 | -- | 0.57969 | 0.59524 | 1 | 
| FQ2 2027 (Jun 2027) | 0.58067 | -- | 0.57391 | 0.58932 | 1 | 
| FQ1 2027 (Mar 2027) | 0.39349 | -- | 0.38891 | 0.39935 | 1 | 
| FQ4 2026 (Oct 2026) | 0.42042 | -- | 0.41361 | 0.42498 | 3 | 
| FQ3 2026 (Jul 2026) | 0.47217 | -- | 0.46453 | 0.47729 | 4 | 
| FQ2 2026 (Jun 2026) | 0.47217 | 4.7 | 0.47217 | 0.47217 | 4 | 
| FQ1 2026 (Mar 2026) | 0.33622 | -1.12 | 0.33063 | 0.34095 | 4 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.87B | -- | 0.86B | 0.87B | 3 | 
| FQ3 2027 (Sep 2027) | 0.85B | -- | 0.84B | 0.86B | 3 | 
| FQ2 2027 (Jun 2027) | 0.86B | -- | 0.86B | 0.87B | 3 | 
| FQ1 2027 (Mar 2027) | 0.79B | -- | 0.78B | 0.8B | 3 | 
| FQ4 2026 (Oct 2026) | 0.79B | -- | 0.78B | 0.8B | 4 | 
| FQ3 2026 (Jul 2026) | 0.8B | -- | 0.79B | 0.81B | 5 | 
| FQ2 2026 (Jun 2026) | 0.8B | 3.56 | 0.8B | 0.8B | 5 | 
| FQ1 2026 (Mar 2026) | 0.74B | 5 | 0.73B | 0.75B | 5 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.45 | 0.45 | 100% | |
| FQ1 2025 (Mar 2025) | 0.34 | 0.34 | 100% | |
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 100% | |
| FQ3 2024 (Sep 2024) | 0.44 | 0.44 | 100% | |
| FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 100% | |
| FQ1 2022 (Mar 2022) | 0.43 | 0.43 | 100% | |
| FQ2 2022 (Jun 2022) | 0.3 | 0.3 | 100% | |
| FQ3 2022 (Sep 2022) | 0.35 | 0.35 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.78B | $776M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $0.71B | $705M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $0.74B | $739M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.73B | $731M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $0.73B | $730M | 100% | 
| FQ1 2022 (Mar 2022) | $0B | $0.62B | $623M | 100% | 
| FQ2 2022 (Jun 2022) | $0B | $0.65B | $645M | 100% | 
| FQ3 2022 (Sep 2022) | $0B | $0.62B | $623M | 100% |